Advertisement

Journal of Gastroenterology

, Volume 48, Issue 6, pp 698–705 | Cite as

Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial

  • Luigina Bonelli
  • Matteo Puntoni
  • Beatrice Gatteschi
  • Paolo Massa
  • Guido Missale
  • Francesco Munizzi
  • Laura Turbino
  • Vincenzo Villanacci
  • Andrea De Censi
  • Paolo Bruzzi
Original Article—Alimentary Tract

Abstract

Background

Patients who undergo polypectomy are at increased risk of adenoma recurrence. The preventive potential of vitamins (A, C and E) and selenium supplementation represent an interesting opportunity for colorectal cancer prevention.

Methods

To assess the efficacy of a combination of these micronutrients in reducing the incidence of recurrent adenomas in subjects on post-polypectomy endoscopic follow-up, a double-blind placebo-controlled randomized trial was started in Italy in 1988. A total of 411 patients were randomized to receive either an active compound (200 μg selenium, 30 mg zinc, 2 mg vitamin A, 180 mg vitamin C, 30 mg vitamin E) or a placebo daily for 5 years. Of them, 330 had follow-up colonoscopy (164 in the intervention and 166 in the placebo group).

Results

After a median follow-up of 4 years (range 1–15 years), 100 patients had recurrence: 38 in the intervention and 62 in the placebo arm. The 15-year cumulative incidence of recurrence was 48.3 % in the intervention and 64.5 % in the placebo arm (HR = 0.59; log-rank P = 0.009). A 39 % reduction of the risk of recurrence was observed in the intervention compared to the placebo group (adjusted HR = 0.61; 95 % CI 0.41–0.92): the risk reduction was similar for small tubular (adjusted HR = 0.61; 95 % CI 0.37–0.99) and advanced adenomas (adjusted HR = 0.50; 95 % CI 0.24–1.01).

Conclusions

Our study showed a statistically significant effect of antioxidant supplementation on adenoma recurrence. Further clinical trials are needed to address the role of antioxidants in subgroups of subjects at increased risk for colorectal cancer.

Keywords

Large bowel Recurrent adenoma Antioxidants 

Notes

Acknowledgments

The authors are grateful to Mrs. Alessandra Guelfi for data management. The study was partially supported by the Italian League Against Cancer (grant Y. 2006) and by the Compagnia di San Paolo (grant no. 2007.0267) to Luigina Bonelli. Pharma Nord provided both the multiagent antioxidant selenium-based compound (Bio-Selenium) and the placebo.

Conflict of interest statement

The authors declare that they have no conflict of interest.

Supplementary material

535_2012_691_MOESM1_ESM.pdf (38 kb)
Supplementary material 1 (PDF 37 kb)

References

  1. 1.
    Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:65–81.CrossRefGoogle Scholar
  2. 2.
    Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenoma-carcinoma sequence. Br J Surg. 2002;89:845–60.PubMedCrossRefGoogle Scholar
  3. 3.
    Cairns SR, Scholefield JH, Steele RJ, et al.; British Society of Gastroenterology; Association of Coloproctology for Great Britain and Ireland. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59:666–89.Google Scholar
  4. 4.
    Salonen JT, Alfthan G, Huttunen JK, Puska P. Association between serum selenium and the risk of cancer. Am J Epidemiol. 1984;120:342–9.PubMedGoogle Scholar
  5. 5.
    Salonen JT, Salonen R, Lappeteläinen R, Mäenpää PH, Alfthan G, Puska P. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J. 1985;290:417–20.CrossRefGoogle Scholar
  6. 6.
    Nomura A, Heilbrun LK, Morris JS, Stemmermann GN. Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. J Natl Cancer Inst. 1987;79:103–8.PubMedGoogle Scholar
  7. 7.
    Wald NJ, Thompson SG, Densem JW, Boreham J, Baley A. Serum beta-carotene, and subsequent the risk of cancer: results from the BUPA study. Br J Cancer. 1988;57:428–33.PubMedCrossRefGoogle Scholar
  8. 8.
    Birt DF, Lawson TA, Julius AD, Runice CE, Salmasi S. Inhibition by dietary selenium of colon cancer induced in the rat by bis (2-oxopropil) nitrosamine. Cancer Res. 1982;42:4455–9.PubMedGoogle Scholar
  9. 9.
    Reddy BS, Sugie S, Maruyama S, El-Bayomy K, Marra P. Chemoprevention of colon carcinogenesis by dietary organoselenium, benzylselenocyanate, in F344 rats. Cancer Res. 1987;47:5901–4.PubMedGoogle Scholar
  10. 10.
    Dion PW, Bright-See EB, Smith CC, Bruce WR. The effect of dietary ascorbic acid and a-Tocopherol on fecal mutagenicity. Mutat Res. 1982;102:27–37.PubMedCrossRefGoogle Scholar
  11. 11.
    Song MK, Adham NF, Heng MC, Costea NV, Heng MK, Ament ME. Metabolic alterations of zinc and prostaglandins in both human and animal colonic tumor cells. J Am Coll Nutr. 1995;14:473–9.PubMedGoogle Scholar
  12. 12.
    Bonelli L, Camoriano A, Ravelli P, Missale G, Bruzzi P, Aste H. Reduction of the incidence of recurrent adenomas of the large bowel by means of antioxidants. In: Palmieri Y, editor. Proceedings of International Selenium Tellurium Development Association. Brussels, Belgium: Se-Te Press; 1998. p. 91–4.Google Scholar
  13. 13.
    Freedman LS, Green SB. Statistical design for investigating several interventions in the same study: methods for cancer prevention trials. J Natl Cancer Inst. 1990;82:910–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Morson BC, Sobin LH. Histological typing of intestinal tumours. Geneva: World Health Organization; 1976. (International histological classification of tumours no. 15).Google Scholar
  15. 15.
    Jass J, Sobin LH. Histological typing of intestinal tumours. II ed. Berlin: Springer; 1989.CrossRefGoogle Scholar
  16. 16.
    Morson BC, Bussey HT. Magnitude of risk for cancer in patients with colorectal adenomas. Br J Surg. 1985;72:S23–5.PubMedCrossRefGoogle Scholar
  17. 17.
    McKeown-Eyssen G, Holloway C, Jazmaji V, Bright-See E, Dion P, Bruce WR. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res. 1988;48:4701–5.PubMedGoogle Scholar
  18. 18.
    Greenberg ER, Baron JA, Tosteson TD, Polyp Prevention Study Group, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med. 1994;331:141–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.CrossRefGoogle Scholar
  20. 20.
    Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patients: II Analysis and examples. Br J Cancer. 1977;35:1–39.PubMedCrossRefGoogle Scholar
  21. 21.
    Cox DR. Regression model and life-tables. J R Stat Soc B. 1972;34:187–220.Google Scholar
  22. 22.
    Malila N, Virtamo J, Virtanen M, Albanes D, Tangrea JA, Huttunen JK. The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer Epidemiol Biomarkers Prev. 1999;8:489–93.PubMedGoogle Scholar
  23. 23.
    Albanes D, Malila N, Taylor PR, Huttunen JK, Virtamo J, Edwards BK. Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland). Cancer Causes Control. 2000;11:197–205.PubMedCrossRefGoogle Scholar
  24. 24.
    Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev. 2008;3:CD004183. Review.PubMedGoogle Scholar
  25. 25.
    Baron JA, Cole BF, Mott L, Haile R, Grau M, Church TR, et al. Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial. J Natl Cancer Inst. 2003;95:717–22.PubMedCrossRefGoogle Scholar
  26. 26.
    Roncucci L, Di Donato P, Carati L, Colorectal Cancer Study Group of the University of Modena and the Health Care District 16, et al. Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Dis Colon Rectum. 1993;36:227–34.PubMedCrossRefGoogle Scholar
  27. 27.
    Hofstad B, Almendingen K, Vatn M, et al. Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion. 1998;59:148–56.PubMedCrossRefGoogle Scholar
  28. 28.
    Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996;276:1957–63.PubMedCrossRefGoogle Scholar
  29. 29.
    Duffield-Lillico AJ, Reid ME, Turnbull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev. 2002;11:630–9.PubMedGoogle Scholar
  30. 30.
    Reid ME, Duffield-Lillico AJ, Sunga A, Fakih M, Alberts DS, Marshall JR. Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. Int J Cancer. 2006;118:1777–81.PubMedCrossRefGoogle Scholar
  31. 31.
    Jacobs ET, Jiang R, Alberts DS, Greenberg ER, Gunter EW, Karagas MR. Selenium and colorectal adenoma: results of a pooled analysis. J Natl Cancer Inst. 2004;96:1669–75.PubMedCrossRefGoogle Scholar
  32. 32.
    Peters U, Chatterjee N, Church TR, et al. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev. 2006;15:315–20.PubMedCrossRefGoogle Scholar
  33. 33.
    Stewart MS, Davis RL, Walsh LP, Pence BC. Induction of differentiation and apoptosis by sodium selenite in human colonic carcinoma cells (HT29). Cancer Lett. 1997;117:35–40.PubMedCrossRefGoogle Scholar
  34. 34.
    Goulet AC, Chigbrow M, Frisk P, Nelson MA. Selenomethionine induces sustained ERK phosphorylation leading to cell–cycle arrest in human colon cancer cells. Carcinogenesis. 2005;26:109–17.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2012

Authors and Affiliations

  • Luigina Bonelli
    • 1
  • Matteo Puntoni
    • 4
  • Beatrice Gatteschi
    • 10
  • Paolo Massa
    • 5
  • Guido Missale
    • 8
  • Francesco Munizzi
    • 2
  • Laura Turbino
    • 6
  • Vincenzo Villanacci
    • 9
  • Andrea De Censi
    • 7
  • Paolo Bruzzi
    • 3
  1. 1.Secondary Prevention and ScreeningIRCCS AOU San Martino-ISTGenoaItaly
  2. 2.Endoscopy UnitIRCCS AOU San Martino-ISTGenoaItaly
  3. 3.Clinical Epidemiology UnitIRCCS AOU San Martino-ISTGenoaItaly
  4. 4.Office of the Scientific DirectorOspedali GallieraGenoaItaly
  5. 5.Gastroenterology UnitOspedali GallieraGenoaItaly
  6. 6.Pathology UnitOspedali GallieraGenoaItaly
  7. 7.Medical Oncology UnitOspedali GallieraGenoaItaly
  8. 8.Unit of Surgical EndoscopyUniversity of BresciaBresciaItaly
  9. 9.Pathology UnitSpedali CiviliBresciaItaly
  10. 10. AOU San Martino-IST (Unit of Pathology)GenoaItaly

Personalised recommendations